Home > Insider Trading > Filing (0000950170-23-043465)

Filing Details

Accession Number:: 0000950170-23-043465
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-18 16:08:07
Reporting Period:: 2023-08-17

Accepted Time:: 2023-08-18 16:08:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1111485	Rxsight Inc.	RXST	Ophthalmic Goods (3851)	943268801

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1431159	Juliet Bakker Tammenoms	C/O Rxsight, Inc. 100 Columbia Aliso Viejo CA 92656		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-08-17	18,484	$30.06	83,062	No	4	S	Direct
Common Stock	Disposition	2023-08-18	14,651	$29.07	68,411	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	994,313	Indirect	See footnote
Common Stock	712,700	Indirect	See footnote
Common Stock	439	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.01 to $30.2921, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 1 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.
Shares held by Longitude Venture Partners II, L.P. ("LVP II"). Longitude Capital Partners II, LLC ("LCP II") is the general partner of LVP II and may be deemed to have voting, investment and dispositive power over the securities held by LVP II. The Reporting Person, a member of the Issuer's board of directors, and Patrick G. Enright are the managing members of LCP II and may be deemed to share voting, investment and dispositive power over the securities held by LVP II. LVP II, LCP II, Mr. Enright and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
Shares held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting, investment and dispositive power over the securities held by LPF. The Reporting Person, a member of the Issuer's board of directors, and Mr. Enright are the managing members of LPP and may be deemed to share voting, investment and dispositive power over the securities held by LPF. LPF, LPP, Mr. Enright and the Reporting Person disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.